These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2151114)

  • 1. Long-term echocardiographic examinations in chronic hemodialysis patients substituted with recombinant human erythropoietin.
    Löw-Friedrich I; Grützmacher P; März W; Bergmann M; Schoeppe W
    Blood Purif; 1990; 8(5):272-8. PubMed ID: 2151114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.
    Löw I; Grützmacher P; Bergmann M; Schoeppe W
    Clin Nephrol; 1989 Jan; 31(1):26-30. PubMed ID: 2521587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients.
    Löw-Friedrich I; Grützmacher P; März W; Bergmann M; Schoeppe W
    Am J Nephrol; 1991; 11(1):54-60. PubMed ID: 1828650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis.
    Martinez-Vea A; Bardají A; García C; Ridao C; Richart C; Oliver JA
    Am J Kidney Dis; 1992 Apr; 19(4):353-7. PubMed ID: 1532883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
    Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
    Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Fernández A; Vega N; Jiménez F; Macía M; Laraudiogoitía E; Hortal L; Perdomo M; Plaza C; Rodríguez JC; Palop L
    Am J Nephrol; 1992; 12(4):207-11. PubMed ID: 1481867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)].
    Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A
    Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
    Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.
    Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Maiorca R
    Clin Nephrol; 1990 Dec; 34(6):272-8. PubMed ID: 2073771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients.
    Zehnder C; Zuber M; Sulzer M; Meyer B; Straumann E; Jenzer HR; Blumberg A
    Nephron; 1992; 61(1):21-5. PubMed ID: 1388250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
    Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
    Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term effects of recombinant human erythropoietin on the cardiovascular system.
    Eschbach JW; Aquiling T; Haley NR; Fan MH; Blagg CR
    Clin Nephrol; 1992; 38 Suppl 1():S98-103. PubMed ID: 1295715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients.
    Satoh K; Masuda T; Ikeda Y; Kurokawa S; Kamata K; Kikawada R; Takamoto T; Marumo F
    Hypertension; 1990 Mar; 15(3):262-6. PubMed ID: 2303284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.
    Silberberg J; Racine N; Barre P; Sniderman AD
    Can J Cardiol; 1990; 6(1):1-4. PubMed ID: 2138048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL; Zezina LIu; Spudass AV
    Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could CAPD modulate the hemodynamic changes induced by rHuEPO treatment?
    Fernández A; Vega N; Hortal L; Jimenez F; Laraudogoitía E; Macía M; Plaza C; Perdomo M; Palop L
    Adv Perit Dial; 1992; 8():435-9. PubMed ID: 1361842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic and functional changes of left ventricle in dialyzed patients after treatment with recombinant human erythropoietin (r-HuEPO).
    Jeren-Struji'c B; Raos V; Jeren T; Horvatin-Godler S
    Angiology; 2000 Feb; 51(2):131-9. PubMed ID: 10701721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.